"It's changed her life incredibly from being a 30-year-old with her life ahead of her to now coming to grips with having ...

It has two lobes, or pieces, one on either side of your ... Has the cancer metastasized (spread) to distant organs, like the lungs or the liver? M0 means the cancer hasn't spread to distant ...

Ian Tollemache is seeking answers after a surgeon mistakenly removed the wrong part of his lung. The Health and Disability ... he had seen where the wrong lobe had been removed.

Our ability to rotate plays a key role in sports performance but also in our daily lives. Here are two exercises to strengthen your rotation and prevent back pain.

Lung cancer screening more than tripled after the U.S. Preventive Services Task Force expanded screening eligibility in 2021, according to a March 20 research letter published in JAMA Oncology. ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

About 1 in every 4 people with lung cancer say they've had back pain at some point since their diagnosis. Lung cancer is usually confirmed with a biopsy. Your doctor will also determine the cancer ...

Tuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...

They devised a 10-day course of tofacitinib to start when the mouse brains fell out of their lull and back into the chaos of seizures. "Honestly, I didn't think it was going to work," Hoffman says.

“I feel like it’s all coming back. Just being out for that long, stuff that I had to go through, wind-wise and lung-wise,” James said. “Just, I think I’ve been getting more comfortable ...

Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response rate of 37% when DS-1062 (datopotamab deruxtecan) was combined with Merck & Co's PD-1 ...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevance that will ...